Biosimilars in Focus for Retina Practices

Welcome to the Biosimilars in Focus for Retina Practices on-demand video series. Join our clinical and business experts in two informative lessons that will enhance your understanding of biosimilars in the community retina space.

Tim Ho, PharmD, BCOP

Regional Clinical Consultant, McKesson

Christine Kern, MBA

Regional Director Managed Care Contracting, McKesson

Key takeaways from these lessons include:

• Understanding the difference between reference drugs and biosimilars, as well as the FDA's position and guidelines
• Learning about the clinical efficacy of biosimilar therapies
• Understanding payer mandates and cost considerations for biosimilars in the retina space
• Learning best practices for dealing with payers

Foundational Science & Retina Pipeline

In the Foundational Science & Retina Pipeline session, Tim explores the basics and clinical efficacy of biosimilars, takes a closer look at the current retina biosimilar pipeline, and discusses the landscape of biosimilar adoption.

Watch to learn more

DOWNLOAD PRESENTATION (PDF, 552 KB)

Payer Mandates

In the Payer Mandates session, Christine will share insights on navigating payer relationships and understanding mandates in the retina space. She discusses best practices, reimbursement models, cost considerations for biosimilars, and understanding benefit plan documents.

Watch to learn more

DOWNLOAD PRESENTATION (PDF, 1.5 MB)